About Intercept Pharma
Intercept Pharmaceuticals is an exciting new company, headquartered in the US. We are building a platform to become a credible partner in progressive, non-viral Liver Diseases to physicians, patients, payers and the broader scientific community. As Intercept develops towards commercialization in 2016, we are creating a European organization full of people who are committed to bringing new innovation in Liver Diseases. We are looking to appoint exceptional staff who can contribute to building a leading European organization that will advance Intercept’s mission of bringing innovative medicines to patients with neglected non-viral chronic liver diseases.